1-205920201-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_052934.4(SLC26A9):c.2085G>A(p.Val695Val) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0703 in 1,613,834 control chromosomes in the GnomAD database, including 4,294 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.070 ( 385 hom., cov: 32)
Exomes 𝑓: 0.070 ( 3909 hom. )
Consequence
SLC26A9
NM_052934.4 synonymous
NM_052934.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.01
Genes affected
SLC26A9 (HGNC:14469): (solute carrier family 26 member 9) This gene is one member of a family of sulfate/anion transporter genes. Family members are well conserved in their genomic (number and size of exons) and protein (aa length among species) structures yet have markedly different tissue expression patterns. The product of this gene is a highly selective chloride ion channel regulated by WNK kinases. Alternative splicing results in multiple transcript variants encoding differing isoforms.[provided by RefSeq, Dec 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.5).
BP6
Variant 1-205920201-C-T is Benign according to our data. Variant chr1-205920201-C-T is described in ClinVar as [Benign]. Clinvar id is 403453.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.01 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0755 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC26A9 | NM_052934.4 | c.2085G>A | p.Val695Val | synonymous_variant | 18/21 | ENST00000367135.8 | NP_443166.1 | |
SLC26A9 | NM_134325.3 | c.2085G>A | p.Val695Val | synonymous_variant | 18/22 | NP_599152.2 | ||
SLC26A9 | XM_011509121.3 | c.1818G>A | p.Val606Val | synonymous_variant | 17/20 | XP_011507423.1 | ||
SLC26A9 | XM_011509122.3 | c.1593G>A | p.Val531Val | synonymous_variant | 15/18 | XP_011507424.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC26A9 | ENST00000367135.8 | c.2085G>A | p.Val695Val | synonymous_variant | 18/21 | 1 | NM_052934.4 | ENSP00000356103.3 | ||
SLC26A9 | ENST00000340781.8 | c.2085G>A | p.Val695Val | synonymous_variant | 17/21 | 1 | ENSP00000341682.4 | |||
SLC26A9 | ENST00000367134.2 | c.2085G>A | p.Val695Val | synonymous_variant | 18/22 | 5 | ENSP00000356102.2 | |||
SLC26A9 | ENST00000491127.5 | n.1469G>A | non_coding_transcript_exon_variant | 10/13 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0700 AC: 10653AN: 152126Hom.: 384 Cov.: 32
GnomAD3 genomes
AF:
AC:
10653
AN:
152126
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0626 AC: 15744AN: 251478Hom.: 621 AF XY: 0.0627 AC XY: 8527AN XY: 135910
GnomAD3 exomes
AF:
AC:
15744
AN:
251478
Hom.:
AF XY:
AC XY:
8527
AN XY:
135910
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0703 AC: 102798AN: 1461590Hom.: 3909 Cov.: 31 AF XY: 0.0700 AC XY: 50889AN XY: 727120
GnomAD4 exome
AF:
AC:
102798
AN:
1461590
Hom.:
Cov.:
31
AF XY:
AC XY:
50889
AN XY:
727120
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0700 AC: 10655AN: 152244Hom.: 385 Cov.: 32 AF XY: 0.0670 AC XY: 4987AN XY: 74442
GnomAD4 genome
AF:
AC:
10655
AN:
152244
Hom.:
Cov.:
32
AF XY:
AC XY:
4987
AN XY:
74442
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
54
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Mar 29, 2016 | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency - |
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at